The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

@article{Kass2002TheOH,
  title={The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.},
  author={M. Andy Kass and Dale K. Heuer and Eve J. Higginbotham and Chris A. Johnson and John L. Keltner and Jessica P Miller and Richard K. Parrish and Mark R. Wilson and Mae O. Gordon},
  journal={Archives of ophthalmology},
  year={2002},
  volume={120 6},
  pages={
          701-13; discussion 829-30
        }
}
BACKGROUND Primary open-angle glaucoma (POAG) is one of the leading causes of blindness in the United States and worldwide. Three to 6 million people in the United States are at increased risk for developing POAG because of elevated intraocular pressure (IOP), or ocular hypertension. There is no consensus on the efficacy of medical treatment in delaying or preventing the onset of POAG in individuals with elevated IOP. Therefore, we designed a randomized clinical trial, the Ocular Hypertension… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 1,116 CITATIONS, ESTIMATED 39% COVERAGE

Brimonidine in the treatment of glaucoma and ocular hypertension

  • Therapeutics and clinical risk management
  • 2006
VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2002
2019

CITATION STATISTICS

  • 71 Highly Influenced Citations

  • Averaged 59 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomized trial

A Heijl, B. Bengstsson
  • Graefes Arch Clin Exp Ophthalmol
  • 2000
VIEW 2 EXCERPTS

Similar Papers

Loading similar papers…